Omeros Hits New 12-Month High at $16.80 (OMER)
Shares of Omeros (NASDAQ:OMER) reached a new 52-week high during mid-day trading on Tuesday , Analyst RN reports. The company traded as high as $16.80 and last traded at $16.15, with a volume of 453,559 shares traded. The stock had previously closed at $15.36.
A number of analysts have recently weighed in on OMER shares. Analysts at Needham & Company LLC reiterated a “buy” rating on shares of Omeros in a research note on Monday, April 7th. They now have a $17.00 price target on the stock, up previously from $15.00. Analysts at WBB Securities raised their price target on shares of Omeros from $20.00 to $30.00 in a research note on Monday, April 7th. They now have a “strong-buy” rating on the stock.
The stock’s 50-day moving average is $12.52 and its 200-day moving average is $11.90. The company’s market cap is $540.9 million.
Omeros (NASDAQ:OMER) last announced its earnings results on Monday, May 12th. The company reported ($0.45) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.45). The company had revenue of $0.10 million for the quarter, compared to the consensus estimate of $0.45 million. During the same quarter last year, the company posted ($0.40) earnings per share. Omeros’s revenue was down 90.9% compared to the same quarter last year. On average, analysts predict that Omeros will post $-1.55 earnings per share for the current fiscal year.
Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.